Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 41189-41190 [2012-17041]
Download as PDF
<![CDATA[
pmangrum on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 134 / Thursday, July 12, 2012 / Notices
Department of Health and Human
Services; the Assistant Secretary for
Health; the Director, CDC; the
Commissioner, Food and Drug
Administration (FDA); and the
Administrator, Centers for Medicare and
Medicaid Services (CMS). The advice
and guidance pertain to general issues
related to improvement in clinical
laboratory quality and laboratory
medicine practice and specific
questions related to possible revision of
the CLIAC standards. Examples include
providing guidance on studies designed
to improve safety, effectiveness,
efficiency, timeliness, equity, and
patient-centeredness of laboratory
services; revisions to the standards
under which clinical laboratories are
regulated; the impact of proposed
revisions to the standards on medical
and laboratory practice; and the
modification of the standards and
provision of non-regulatory guidelines
to accommodate technological
advances, such as new test methods and
the electronic transmission of laboratory
information.
Matters To Be Discussed: The agenda
will include agency updates from the
CDC, the CMS, and the FDA; and
presentations and discussions
addressing activities of the Clinical
Laboratory Integration into Health Care
Collaborative (CLIHC); the Laboratory
Medicine Best Practices (LMBP)
Initiative; the Communication in
Informatics Workgroup; and the topic of
usability of electronic health records.
Also discussed will be the potential
need for educational materials and
resources for sites that test under a
Provider-performed Microscopy
Certificate; and the increased use of
culture-independent microbiology
diagnostics and the impact on public
health.
Agenda items are subject to change as
priorities dictate.
Providing Oral or Written Comments:
It is the policy of CLIAC to accept
written public comments and provide a
brief period for oral public comments
whenever possible.
Oral Comments: In general, each
individual or group requesting to make
an oral presentation will be limited to
a total time of five minutes (unless
otherwise indicated). Speakers must
also submit their comments in writing
for inclusion in the meeting’s Summary
Report. To assure adequate time is
scheduled for public comments,
individuals or groups planning to make
an oral presentation should, when
possible, notify the contact person
below at least one week prior to the
meeting date. Written Comments: For
individuals or groups unable to attend
VerDate Mar<15>2010
15:39 Jul 11, 2012
Jkt 226001
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, it is
requested that comments be submitted
at least one week prior to the meeting
date so that the comments may be made
available to the Committee for their
consideration and public distribution.
Written comments, one hard copy with
original signature, should be provided
to the contact person below. Written
comments will be included in the
meeting’s Summary Report.
Availability of Meeting Materials: To
support the green initiatives of the
federal government, the CLIAC meeting
materials will be made available to the
Committee and the public in electronic
format (PDF) on the internet instead of
by printed copy. Refer to the CLIAC
Web site on the day of the meeting for
materials. https://wwwn.cdc.gov/cliac/
cliac_meeting_all_documents.aspx.
Note: If using a mobile device to access the
materials, please verify the device’s browser
is able to download the files from the CDC’s
Web site before the meeting. Alternatively,
the files can be downloaded to a computer
and then emailed to the portable device. An
internet connection, power source and
limited hard copies may be available at the
meeting location, but cannot be guaranteed.
Contact Person for Additional
Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch,
Division of Laboratory Science and
Standards, Laboratory Science, Policy
and Practice Program Office, Office of
Surveillance, Epidemiology and
Laboratory Services, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., Mailstop F–11, Atlanta,
Georgia 30333; telephone (404) 498–
2741; fax (404) 498–2219; or via email
at NAnderson@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 2, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–17024 Filed 7–11–12; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
41189
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–5 p.m.,
Eastern Time, August 6, 2012.
Place: Cincinnati Airport Marriott,
2395 Progress Drive, Hebron, Kentucky
41018, Telephone: (859) 334–4611, Fax:
(859) 334–4619.
Status: Open to the public, but
without an oral public comment period.
To access by conference call dial the
following information: 1 (866) 659–
0537, Participant Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2013.
Purpose: The Advisory Board is
charged with (a) Providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
E:\FR\FM\12JYN1.SGM
12JYN1
pmangrum on DSK3VPTVN1PROD with NOTICES
41190
Federal Register / Vol. 77, No. 134 / Thursday, July 12, 2012 / Notices
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes:
revisiting the Board’s dose
reconstruction review process; dose
reconstruction program quality
management and assurance activities,
including an overview of contractor
quality management system and an
update on the results of NIOSH internal
dose reconstruction blind reviews; dose
reconstruction issues from NIOSH 10year review, including review of
resource impact of possible changes to
efficiency process and plans for a
NIOSH Division of Compensation
Analysis and Support claimant
favorability analysis; discussion of dose
reconstruction cases under review (sets
8–9, cases with Category A findings
from sets 10–13, Savannah River Site
cases from sets 10–13); and preselection of set 16 dose reconstruction
cases to be reviewed by the Board’s
technical support contractor.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone: (513) 533–6800, Toll
Free 1 (800) CDC–INFO, Email:
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Mar<15>2010
15:39 Jul 11, 2012
Jkt 226001
Dated: July 6, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–17041 Filed 7–11–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–190]
Revised Document Posted: NIOSH List
of Antineoplastic and Other Hazardous
Drugs in Healthcare Settings 2012,
Correction
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: A notice of issuance of Final
Guidance Publication was published in
the Federal Register June 27, 2012, (77
FR 38297). This notice is corrected as
follows:
AGENCY:
On page 38297, the Docket number
has been changed to NIOSH–190.
FOR FURTHER INFORMATION CONTACT:
Barbara MacKenzie, NIOSH, Robert A.
Taft Laboratories, 4676 Columbia
Parkway, MS–C26, Cincinnati, OH
45226, Telephone (513) 533–8132, email
hazardousdrugs@cdc.gov.
Dated: July 6, 2012.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2012–17002 Filed 7–11–12; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Office of Clinical and Preventive
Services Funding Opportunity:
National HIV Program for Enhanced
HIV/AIDS Screening and Engagement
in Care
Indian Health Service, HHS
ACTION: Notice: correction.
AGENCY:
The Indian Health Service
published a document in the Federal
Register on June 19, 2012, concerning
Announcement Type: New. Funding
Announcement Number: HHS–2012–
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
IHS–OCPS–HIV–0001. Catalog of
Federal Domestic Assistance Number:
93.933. The document contained five
incorrect dates.
FOR FURTHER INFORMATION CONTACT: Dr.
Charlene Avery, Director, Office of
Clinical and Preventative Services,
Indian Health Service, 801 Thompson
Avenue, Suite 300, Reyes Building,
Rockville, MD 20852, Telephone 301–
443–1190. (This is not a toll-free
number.)
Corrections
In the Federal Register of June 19,
2012, in FR DOC 2012–14891, on page
36550, in the third column, under the
heading ‘‘Dates: Key Dates:’’
‘‘Application Deadline Date: July 16,
2012.’’ should read ‘‘July 20, 2012.’’ On
page 36552, in the first column, under
the heading ‘‘Proof of Non-Profit
Status’’; ‘‘A copy of the 501(c)(3)
Certificate must be received with your
application submission by the deadline
date of July 16, 2012.’’ should read ‘‘A
copy of the 501(c)(3) Certificate must be
received with your application
submission by the deadline date of July
20, 2012.’’ On page 36553, in the first
column, under the heading ‘‘3.
Submission Dates and Times’’
‘‘Applications must be submitted
electronically through Grants.gov by
12:00 a.m., midnight Eastern Daylight
Time (EDT) on July 16, 2012’’ should
read ‘‘Applications must be submitted
electronically through Grants.gov by
12:00 a.m., midnight Eastern Daylight
Time (EDT) on July 20, 2012.’’ On page
36553, in the second column, under the
heading ‘‘Proof of Non-Profit Status:’’
‘‘Due Date July 16, 2012’’ should read
‘‘Due Date July 20, 2012.’’ On page
36553, in the third column, under the
fourth bullet ‘‘If the waiver is approved,
the application should be sent directly
to the DGM by the deadline date of July
16, 2012.’’ should read ‘‘If the waiver is
approved, the application should be
sent directly to the DGM by the deadline
date of July 20, 2012.’’
Dated: July 2, 2012.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2012–17047 Filed 7–11–12; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Office of Urban Indian Health
Programs Funding Opportunity: Title V
HIV/AIDS Program
AGENCY:
E:\FR\FM\12JYN1.SGM
Indian Health Service, HHS.
12JYN1
]]>Agencies
[Federal Register Volume 77, Number 134 (Thursday, July 12, 2012)]
[Notices]
[Pages 41189-41190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17041]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 8:30 a.m.-5 p.m., Eastern Time, August 6, 2012.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018, Telephone: (859) 334-4611, Fax: (859) 334-4619.
Status: Open to the public, but without an oral public comment
period. To access by conference call dial the following information: 1
(866) 659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2013.
Purpose: The Advisory Board is charged with (a) Providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific
[[Page 41190]]
validity and quality of dose reconstruction efforts performed for this
program; and (c) upon request by the Secretary, HHS, advise the
Secretary on whether there is a class of employees at any Department of
Energy facility who were exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and on whether there is
reasonable likelihood that such radiation doses may have endangered the
health of members of this class. The Subcommittee for Dose
Reconstruction Reviews was established to aid the Advisory Board in
carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes: revisiting the Board's dose reconstruction review process;
dose reconstruction program quality management and assurance
activities, including an overview of contractor quality management
system and an update on the results of NIOSH internal dose
reconstruction blind reviews; dose reconstruction issues from NIOSH 10-
year review, including review of resource impact of possible changes to
efficiency process and plans for a NIOSH Division of Compensation
Analysis and Support claimant favorability analysis; discussion of dose
reconstruction cases under review (sets 8-9, cases with Category A
findings from sets 10-13, Savannah River Site cases from sets 10-13);
and pre-selection of set 16 dose reconstruction cases to be reviewed by
the Board's technical support contractor.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone: (513) 533-6800, Toll Free 1 (800) CDC-INFO,
Email: ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: July 6, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-17041 Filed 7-11-12; 8:45 am]
BILLING CODE 4163-18-P
